Skip to main content

Table 3 Clinical data of family members with diabetes mellitus or impaired fasting glucose

From: Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)

Patients

Family member

DM/IFG diagnosed age (years)

Treatment

At genetic confirmation of GCK-MODY

    

Age (years)

BMI

(kg/m2)

FPG (mmol/L)

HbA1c (%/

mmol/mol)

Case 1

Father

32

No

37

20.4

6.5

7.1/54.1

Case 2

Father

35

No

38

19.5

7.1

6.9/51.9

Grandmother

51

Glibenclamide

65

22.5

6.8

7.1/54.1

Case 3

Mother

29

20.5

6.4

6.8/50.8

Case 4

Mother

42

No

46

21.5

5.8

6.3/45.4

Case 5

Mother

39

Diet, active exercise

42

21.8

6.1

6.2/44.3

Case 6

Mother

35

20.9

7.8

6.4/46.5

Grandfather

50

Metformin

70

22.7

6.3

6.5/47.5

Case 7

Father

37

24.1

6.2

6.4/46.5

Case 8

Mother

37

25.1

7.0

6.9/51.9

Grandmother

42

Metformin for 2 years and wean off at age of 44 years

64

23.6

6.3

7.4/57.4

Case 9

Father

36

Metformin

39

21.8

6.9

7.0/53.0

Grandfather

40

No

65

21.6

6.5

6.5/47.5

  1. DM diabetes mellitus, IFG impaired fasting glucose, BMI body mass index, FPG fasting plasma glucose